Trephine
AboutSpecialtiesPricingLoading...

Copyright © 2024 Trephine. All rights reserved. The content of this site is intended for health care professionals.

TREPHINE

Terms Of UsePrivacy Policy

Regional anesthesia and pain medicineRandomized Controlled Trial

06 May 2025

Effect of virtual reality hypnosis on intraoperative sedation needs and functional recovery in knee arthroplasty: a prospective randomized clinical trial.

Background and objectives

Perioperative psychological stress and pharmacological anxiolysis can negatively affect the quality of recovery after total knee arthroplasty. We aimed to assess whether hypnosis combined with virtual reality could reduce intraoperative pharmacological sedation and improve quality of recovery after total knee arthroplasty surgery.

Methods

In this prospective randomized clinical trial, 60 patients scheduled for total knee arthroplasty with spinal anesthesia were randomly divided into 2 groups of 30 patients each. Intraoperatively, intermittent boluses of midazolam 1 mg were administered at 5 min intervals at the patient's request, with a maximum driven by the clinical assessment of sedation depth. During surgery, patients received standard care (group control) or virtual reality hypnosis (group VRH). An unblinded observer recorded the total dose of midazolam administered during surgery, and changes in the Quality-of-Recovery 15-item score, comfort, fatigue, pain and anxiety before and 1, 3 and 7 days after surgery.

Results

Patients in the VRH group required a lower dose of midazolam (mg; median (range)) intraoperatively (group VRH: 0 (0-4) and group control: 2 (0-9), p<0.001). Quality-of-Recovery 15-item, anxiety, and pain were similar between groups.

Conclusions

In total knee arthroplasty with spinal anesthesia, VRH reduces the requirement for intraoperative pharmacological sedation, without a change in the quality of recovery.

Trial registration number

NCT05707234.

COI Statement

Competing interests: MC has received interview and speaker’s honoraria from GE Healthcare, Baxter and Aguettant He is member of the Belgian Association for Regional Anesthesia Board. VLB has received funds and research support from Orion Pharma as well as honoraria from Medtronic. He has financial relationships with Grünenthal. He is Deputy Editor-in-Chief of the Acta Anaesthesiologica Belgica, and has a consultancy contract with Edwards Medical. CQ was employee at Oncomfort at the time the study was conducted. Other authors declare no conflicts of interest.

Article info

Journal issue:

  • Volume: 50
  • Issue: 5

Doi:

10.1136/rapm-2023-105261

More resources:

HighWire

Full Text Sources

Paid

MedlinePlus Health Information

Medical

Free resource

Share: